resorcinol has been researched along with methimazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Motonaga, K; Odawara, K; Ota, M; Saito, S; Welsch, F | 1 |
1 review(s) available for resorcinol and methimazole
| Article | Year |
|---|---|
A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Autoantigens; Biomarkers; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gestational Age; Humans; Iodide Peroxidase; Iron-Binding Proteins; Methimazole; Neurotoxicity Syndromes; Pregnancy; Propylthiouracil; Rats; Resorcinols; Risk Assessment; Thyroid Gland; Thyroid Hormones | 2016 |
1 other study(ies) available for resorcinol and methimazole
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |